Topics

DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837

09:50 EDT 18 May 2019 | Synbiobeta

Having reached a sufficient number of clinical centers, Phase II clinical trial testing the antibiotic candidate DNV3837 in Clostridioides1 (Clostridium) difficile infections will start this summer in the United States and Germany This trial will be conducted as part of an active Investigational New Drug (IND) authorization and a recently updated version of the clinical […]

The post DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837 appeared first on SynBioBeta.

Original Article: DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837

NEXT ARTICLE

More From BioPortfolio on "DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clostridium difficile (CDI)
A clostridium difficile infection (CDI) is a type of bacterial infection that can affect the digestive system. It most commonly affects people who are staying in hospital.  The symptoms of CDI can range from mild to severe and include: diarrhoe...